Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Nervous System Diseases | 15 | 2023 | 708 | 3.730 |
Why?
|
Complex Regional Pain Syndromes | 13 | 2016 | 121 | 3.610 |
Why?
|
Polyneuropathies | 11 | 2023 | 137 | 3.470 |
Why?
|
Herpes Zoster | 17 | 2012 | 251 | 2.460 |
Why?
|
Pruritus | 12 | 2019 | 377 | 2.440 |
Why?
|
Immunoglobulins, Intravenous | 5 | 2022 | 664 | 2.120 |
Why?
|
Fibromyalgia | 5 | 2020 | 398 | 1.990 |
Why?
|
Reflex Sympathetic Dystrophy | 8 | 2014 | 58 | 1.870 |
Why?
|
Neuralgia | 12 | 2020 | 597 | 1.780 |
Why?
|
Tarlov Cysts | 5 | 2023 | 12 | 1.570 |
Why?
|
Nerve Fibers | 8 | 2016 | 708 | 1.470 |
Why?
|
Adrenal Cortex Hormones | 6 | 2022 | 1870 | 1.370 |
Why?
|
Pain | 15 | 2022 | 5066 | 1.320 |
Why?
|
Erythromelalgia | 4 | 2020 | 15 | 1.250 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | 2019 | 33 | 1.180 |
Why?
|
Plasma Exchange | 2 | 2019 | 158 | 1.130 |
Why?
|
Tibial Nerve | 4 | 2012 | 50 | 1.000 |
Why?
|
Skin | 16 | 2023 | 4468 | 0.940 |
Why?
|
Cold Temperature | 3 | 2016 | 780 | 0.830 |
Why?
|
Pain Threshold | 3 | 2016 | 600 | 0.820 |
Why?
|
Peroneal Neuropathies | 1 | 2021 | 21 | 0.770 |
Why?
|
Tibial Neuropathy | 2 | 2010 | 4 | 0.710 |
Why?
|
Axons | 7 | 2023 | 1672 | 0.700 |
Why?
|
Needlestick Injuries | 2 | 2012 | 71 | 0.680 |
Why?
|
Statistics, Nonparametric | 2 | 2016 | 2852 | 0.680 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.670 |
Why?
|
Wallerian Degeneration | 4 | 2012 | 68 | 0.640 |
Why?
|
Thoracic Vertebrae | 2 | 2013 | 597 | 0.610 |
Why?
|
Fabry Disease | 1 | 2018 | 85 | 0.610 |
Why?
|
Leg | 2 | 2021 | 1091 | 0.570 |
Why?
|
Central Nervous System Diseases | 2 | 2012 | 521 | 0.570 |
Why?
|
Neurites | 4 | 2020 | 389 | 0.560 |
Why?
|
Sjogren's Syndrome | 1 | 2018 | 235 | 0.540 |
Why?
|
Pain Measurement | 8 | 2019 | 3514 | 0.530 |
Why?
|
Occult Blood | 1 | 2016 | 197 | 0.510 |
Why?
|
Neuralgia, Postherpetic | 3 | 2010 | 41 | 0.510 |
Why?
|
Hematologic Tests | 1 | 2016 | 238 | 0.510 |
Why?
|
Nociceptors | 6 | 2020 | 457 | 0.500 |
Why?
|
Trigeminal Nerve Diseases | 2 | 2012 | 49 | 0.480 |
Why?
|
Review Literature as Topic | 1 | 2017 | 350 | 0.480 |
Why?
|
Nerve Endings | 2 | 2007 | 105 | 0.470 |
Why?
|
Electrodiagnosis | 3 | 2022 | 148 | 0.460 |
Why?
|
Ophthalmic Nerve | 1 | 2013 | 42 | 0.430 |
Why?
|
Radiculopathy | 2 | 2013 | 200 | 0.430 |
Why?
|
Neurons, Afferent | 5 | 2006 | 498 | 0.430 |
Why?
|
Biopsy | 9 | 2023 | 6775 | 0.420 |
Why?
|
Cranial Nerve Diseases | 1 | 2013 | 112 | 0.420 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2012 | 36 | 0.410 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2015 | 269 | 0.410 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2012 | 56 | 0.400 |
Why?
|
Peripheral Nerves | 4 | 2012 | 475 | 0.380 |
Why?
|
Sacrum | 2 | 2015 | 281 | 0.380 |
Why?
|
Neck Pain | 1 | 2012 | 186 | 0.370 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2006 | 623 | 0.370 |
Why?
|
Injections, Epidural | 1 | 2012 | 200 | 0.360 |
Why?
|
Spinal Nerve Roots | 2 | 2023 | 121 | 0.360 |
Why?
|
Trauma, Nervous System | 1 | 2010 | 35 | 0.360 |
Why?
|
Biomedical Research | 3 | 2016 | 3421 | 0.360 |
Why?
|
Humans | 96 | 2024 | 760261 | 0.360 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2012 | 246 | 0.350 |
Why?
|
Lateral Medullary Syndrome | 1 | 2009 | 9 | 0.350 |
Why?
|
Psychometrics | 2 | 2017 | 3049 | 0.350 |
Why?
|
Sural Nerve | 2 | 2012 | 106 | 0.330 |
Why?
|
Anticonvulsants | 4 | 2013 | 1881 | 0.320 |
Why?
|
Posterior Horn Cells | 1 | 2008 | 90 | 0.310 |
Why?
|
Ganglia, Spinal | 4 | 2020 | 523 | 0.300 |
Why?
|
Hyperalgesia | 2 | 2012 | 530 | 0.300 |
Why?
|
Afferent Pathways | 2 | 2006 | 299 | 0.300 |
Why?
|
Somatosensory Cortex | 1 | 2012 | 511 | 0.300 |
Why?
|
Neural Inhibition | 1 | 2012 | 589 | 0.300 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 3 | 2019 | 41 | 0.290 |
Why?
|
Neural Conduction | 4 | 2019 | 441 | 0.290 |
Why?
|
Disease Management | 1 | 2018 | 2508 | 0.290 |
Why?
|
Terminology as Topic | 1 | 2014 | 1534 | 0.290 |
Why?
|
Spinal Cord Injuries | 2 | 2012 | 923 | 0.280 |
Why?
|
Nerve Fibers, Unmyelinated | 2 | 2020 | 97 | 0.270 |
Why?
|
Cervical Vertebrae | 1 | 2012 | 978 | 0.270 |
Why?
|
Disease Models, Animal | 11 | 2018 | 18134 | 0.270 |
Why?
|
Sensory Receptor Cells | 4 | 2020 | 509 | 0.270 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4923 | 0.270 |
Why?
|
Neuroglia | 3 | 2008 | 944 | 0.260 |
Why?
|
Herpesvirus 3, Human | 4 | 2010 | 159 | 0.260 |
Why?
|
Cornea | 1 | 2013 | 1325 | 0.250 |
Why?
|
Guillain-Barre Syndrome | 1 | 2007 | 125 | 0.250 |
Why?
|
Immunotherapy | 2 | 2024 | 4637 | 0.250 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2006 | 93 | 0.240 |
Why?
|
Foot Deformities, Acquired | 1 | 2004 | 27 | 0.240 |
Why?
|
Medical History Taking | 1 | 2008 | 773 | 0.240 |
Why?
|
Female | 49 | 2024 | 391011 | 0.240 |
Why?
|
Male | 47 | 2023 | 359413 | 0.240 |
Why?
|
Hemangioma, Cavernous | 1 | 2005 | 107 | 0.230 |
Why?
|
Axotomy | 3 | 2010 | 71 | 0.230 |
Why?
|
Fibrin Tissue Adhesive | 2 | 2015 | 85 | 0.230 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4168 | 0.230 |
Why?
|
Epidermis | 2 | 2004 | 529 | 0.230 |
Why?
|
Behavior, Animal | 1 | 2012 | 1861 | 0.220 |
Why?
|
Sciatic Nerve | 5 | 2012 | 612 | 0.220 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2008 | 1132 | 0.210 |
Why?
|
Varicose Veins | 1 | 2004 | 155 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.210 |
Why?
|
Rats, Sprague-Dawley | 7 | 2012 | 8157 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.210 |
Why?
|
Adult | 27 | 2024 | 219847 | 0.200 |
Why?
|
Nerve Degeneration | 5 | 2001 | 748 | 0.200 |
Why?
|
Langerhans Cells | 1 | 2002 | 171 | 0.200 |
Why?
|
Joint Diseases | 1 | 2006 | 458 | 0.200 |
Why?
|
Hindlimb | 1 | 2004 | 510 | 0.200 |
Why?
|
Spinal Cord Diseases | 1 | 2005 | 293 | 0.200 |
Why?
|
Low Back Pain | 1 | 2010 | 979 | 0.200 |
Why?
|
Diffusion Tensor Imaging | 1 | 2012 | 2383 | 0.200 |
Why?
|
Vulvar Diseases | 1 | 2002 | 62 | 0.200 |
Why?
|
Ubiquitin Thiolesterase | 4 | 2019 | 454 | 0.190 |
Why?
|
Peroneal Nerve | 1 | 2021 | 76 | 0.190 |
Why?
|
Electromyography | 3 | 2016 | 1386 | 0.190 |
Why?
|
Brain Edema | 1 | 2005 | 603 | 0.180 |
Why?
|
Rats | 12 | 2012 | 23695 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8621 | 0.180 |
Why?
|
Sensation Disorders | 2 | 2017 | 160 | 0.170 |
Why?
|
Angiotensins | 1 | 2020 | 143 | 0.170 |
Why?
|
Dystonic Disorders | 1 | 2004 | 340 | 0.170 |
Why?
|
Reproducibility of Results | 4 | 2023 | 20048 | 0.170 |
Why?
|
Evidence-Based Medicine | 3 | 2012 | 3696 | 0.170 |
Why?
|
Functional Laterality | 3 | 2008 | 2253 | 0.170 |
Why?
|
Hospitals, General | 1 | 2023 | 795 | 0.170 |
Why?
|
Methylprednisolone | 2 | 2020 | 384 | 0.160 |
Why?
|
Data Interpretation, Statistical | 3 | 2015 | 2696 | 0.160 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2021 | 215 | 0.160 |
Why?
|
Brain | 3 | 2016 | 26912 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 361 | 0.160 |
Why?
|
Neurologic Examination | 1 | 2022 | 916 | 0.160 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12968 | 0.160 |
Why?
|
Severity of Illness Index | 2 | 2015 | 15827 | 0.160 |
Why?
|
Joint Instability | 1 | 2006 | 795 | 0.160 |
Why?
|
Ion Channels | 2 | 2018 | 1043 | 0.150 |
Why?
|
Aged | 23 | 2021 | 168995 | 0.150 |
Why?
|
Middle Aged | 26 | 2022 | 220175 | 0.150 |
Why?
|
Electric Stimulation Therapy | 3 | 2010 | 613 | 0.150 |
Why?
|
Brain Diseases | 1 | 2006 | 1540 | 0.140 |
Why?
|
Axonal Transport | 2 | 1988 | 178 | 0.140 |
Why?
|
Foot | 2 | 2012 | 573 | 0.140 |
Why?
|
Skin Physiological Phenomena | 2 | 2008 | 189 | 0.140 |
Why?
|
Analgesics | 4 | 2020 | 1066 | 0.130 |
Why?
|
Ganglia, Sensory | 1 | 2016 | 19 | 0.130 |
Why?
|
Treatment Outcome | 9 | 2022 | 64947 | 0.130 |
Why?
|
Sodium Channels | 1 | 1997 | 344 | 0.130 |
Why?
|
Blood Sedimentation | 1 | 2016 | 234 | 0.130 |
Why?
|
Azathioprine | 1 | 2017 | 356 | 0.130 |
Why?
|
Adolescent | 10 | 2020 | 87747 | 0.120 |
Why?
|
Dysautonomia, Familial | 1 | 2016 | 95 | 0.120 |
Why?
|
Antibodies, Antinuclear | 1 | 2016 | 344 | 0.120 |
Why?
|
Animals | 22 | 2019 | 167940 | 0.120 |
Why?
|
Serine | 1 | 2019 | 831 | 0.120 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 130 | 0.120 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2020 | 952 | 0.120 |
Why?
|
Shoes | 1 | 2014 | 94 | 0.120 |
Why?
|
Sweating | 1 | 2015 | 154 | 0.110 |
Why?
|
Cell Count | 2 | 2012 | 1838 | 0.110 |
Why?
|
RNA, Messenger | 4 | 2016 | 12762 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2017 | 939 | 0.110 |
Why?
|
History, 20th Century | 3 | 2008 | 2777 | 0.110 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14482 | 0.110 |
Why?
|
Exercise Test | 1 | 2021 | 2125 | 0.110 |
Why?
|
Paraneoplastic Syndromes | 1 | 2014 | 155 | 0.100 |
Why?
|
Gait Disorders, Neurologic | 1 | 2014 | 238 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 4 | 2013 | 36247 | 0.100 |
Why?
|
Mitosis | 2 | 1988 | 1193 | 0.100 |
Why?
|
Prednisone | 1 | 2017 | 1566 | 0.100 |
Why?
|
Young Adult | 9 | 2019 | 58673 | 0.100 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2013 | 432 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 920 | 0.100 |
Why?
|
Physical Stimulation | 2 | 2012 | 518 | 0.100 |
Why?
|
Peripheral Vascular Diseases | 1 | 2015 | 515 | 0.100 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 370 | 0.090 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2013 | 625 | 0.090 |
Why?
|
DNA, Complementary | 1 | 1994 | 1993 | 0.090 |
Why?
|
Movement Disorders | 1 | 2015 | 459 | 0.090 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7468 | 0.090 |
Why?
|
Pregnancy Complications | 1 | 2024 | 2940 | 0.090 |
Why?
|
Antiviral Agents | 3 | 2010 | 3061 | 0.090 |
Why?
|
Fecal Incontinence | 1 | 2013 | 242 | 0.090 |
Why?
|
Fasting | 1 | 2016 | 1603 | 0.090 |
Why?
|
Schwann Cells | 2 | 1988 | 196 | 0.090 |
Why?
|
Methotrexate | 1 | 2017 | 1717 | 0.090 |
Why?
|
Sample Size | 1 | 2013 | 840 | 0.090 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1256 | 0.080 |
Why?
|
Aged, 80 and over | 8 | 2017 | 58947 | 0.080 |
Why?
|
Nerve Compression Syndromes | 1 | 2011 | 160 | 0.080 |
Why?
|
Dexamethasone | 1 | 2017 | 1928 | 0.080 |
Why?
|
Autopsy | 1 | 2013 | 1007 | 0.080 |
Why?
|
Thalidomide | 1 | 2014 | 884 | 0.080 |
Why?
|
Versicans | 1 | 2008 | 40 | 0.080 |
Why?
|
ROC Curve | 1 | 2017 | 3568 | 0.080 |
Why?
|
Syndrome | 2 | 2012 | 3278 | 0.080 |
Why?
|
Urinary Incontinence | 1 | 2013 | 496 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2007 | 15680 | 0.080 |
Why?
|
Substance P | 1 | 2009 | 333 | 0.080 |
Why?
|
Retinal Diseases | 1 | 2014 | 702 | 0.070 |
Why?
|
Paclitaxel | 2 | 2013 | 1738 | 0.070 |
Why?
|
Causalgia | 1 | 2007 | 5 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2015 | 1007 | 0.070 |
Why?
|
Iatrogenic Disease | 1 | 2010 | 538 | 0.070 |
Why?
|
Walking | 1 | 2014 | 1190 | 0.070 |
Why?
|
Saxitoxin | 2 | 1984 | 65 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1972 | 0.070 |
Why?
|
Spinal Nerves | 1 | 2007 | 91 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8058 | 0.070 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2008 | 550 | 0.070 |
Why?
|
Lectins | 1 | 2008 | 485 | 0.070 |
Why?
|
Avitaminosis | 1 | 2006 | 35 | 0.070 |
Why?
|
Nucleotides | 1 | 2008 | 450 | 0.070 |
Why?
|
Neurons | 3 | 2018 | 9416 | 0.070 |
Why?
|
Blood Vessels | 1 | 2012 | 1112 | 0.070 |
Why?
|
Chest Pain | 1 | 2013 | 1106 | 0.060 |
Why?
|
Malingering | 1 | 2006 | 75 | 0.060 |
Why?
|
Patellar Dislocation | 1 | 2006 | 66 | 0.060 |
Why?
|
History, 19th Century | 1 | 2008 | 720 | 0.060 |
Why?
|
Time Factors | 5 | 2015 | 40133 | 0.060 |
Why?
|
Boronic Acids | 1 | 2009 | 914 | 0.060 |
Why?
|
Shoulder Dislocation | 1 | 2006 | 129 | 0.060 |
Why?
|
Endothelium | 1 | 1987 | 764 | 0.060 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2014 | 1067 | 0.060 |
Why?
|
Altitude Sickness | 1 | 2005 | 91 | 0.060 |
Why?
|
Mast Cells | 1 | 2012 | 1428 | 0.060 |
Why?
|
Soccer | 1 | 2006 | 141 | 0.060 |
Why?
|
Shoulder Joint | 1 | 2011 | 730 | 0.060 |
Why?
|
Sensation | 1 | 2005 | 331 | 0.060 |
Why?
|
Laminectomy | 1 | 2005 | 224 | 0.060 |
Why?
|
Germany | 1 | 2006 | 875 | 0.060 |
Why?
|
Hypesthesia | 1 | 2004 | 107 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2013 | 1589 | 0.060 |
Why?
|
Tremor | 1 | 2004 | 187 | 0.050 |
Why?
|
Child | 4 | 2020 | 79758 | 0.050 |
Why?
|
Pain Insensitivity, Congenital | 1 | 2003 | 9 | 0.050 |
Why?
|
Pyrazines | 1 | 2009 | 1200 | 0.050 |
Why?
|
Retina | 1 | 2014 | 2635 | 0.050 |
Why?
|
Anesthetics, Local | 2 | 2013 | 1001 | 0.050 |
Why?
|
Lumbosacral Region | 1 | 2004 | 291 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2004 | 630 | 0.050 |
Why?
|
Anterior Cruciate Ligament | 1 | 2006 | 423 | 0.050 |
Why?
|
Pregnancy | 1 | 2024 | 29725 | 0.050 |
Why?
|
Inflammation | 2 | 2015 | 10757 | 0.050 |
Why?
|
Electrodes, Implanted | 1 | 2007 | 833 | 0.050 |
Why?
|
Mice | 5 | 2018 | 81216 | 0.050 |
Why?
|
History, 21st Century | 1 | 2008 | 1576 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6375 | 0.050 |
Why?
|
Self Mutilation | 1 | 2002 | 58 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11064 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.050 |
Why?
|
Frontal Bone | 1 | 2002 | 105 | 0.050 |
Why?
|
Cell Survival | 1 | 2012 | 5796 | 0.050 |
Why?
|
Lidocaine | 1 | 2005 | 538 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6210 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 8018 | 0.050 |
Why?
|
Stress, Mechanical | 1 | 2006 | 1666 | 0.050 |
Why?
|
Glycoproteins | 1 | 2008 | 2208 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2250 | 0.050 |
Why?
|
Osteotomy | 1 | 2006 | 835 | 0.050 |
Why?
|
Thiolester Hydrolases | 1 | 2001 | 85 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1601 | 0.050 |
Why?
|
Bone Diseases, Metabolic | 1 | 2004 | 409 | 0.050 |
Why?
|
Myelin Sheath | 1 | 1984 | 651 | 0.040 |
Why?
|
Thorax | 1 | 2003 | 553 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10340 | 0.040 |
Why?
|
Gastrin-Releasing Peptide | 1 | 2019 | 37 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6181 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1791 | 0.040 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2019 | 42 | 0.040 |
Why?
|
Neck | 1 | 2003 | 730 | 0.040 |
Why?
|
Radiotherapy | 1 | 2005 | 1505 | 0.040 |
Why?
|
Herpes Zoster Vaccine | 2 | 2010 | 49 | 0.040 |
Why?
|
Phenotype | 2 | 2021 | 16543 | 0.040 |
Why?
|
Extremities | 1 | 2003 | 867 | 0.040 |
Why?
|
Research | 1 | 2006 | 1973 | 0.040 |
Why?
|
Knee Joint | 1 | 2006 | 1662 | 0.040 |
Why?
|
Sphingolipids | 1 | 2019 | 173 | 0.040 |
Why?
|
Face | 1 | 2003 | 1017 | 0.040 |
Why?
|
Genitalia | 1 | 2017 | 113 | 0.030 |
Why?
|
Spine | 1 | 2023 | 1111 | 0.030 |
Why?
|
Reoperation | 1 | 2007 | 4292 | 0.030 |
Why?
|
Cats | 2 | 1988 | 976 | 0.030 |
Why?
|
Autonomic Pathways | 1 | 2016 | 31 | 0.030 |
Why?
|
Ion Channel Gating | 1 | 1997 | 436 | 0.030 |
Why?
|
Spinocerebellar Degenerations | 1 | 2014 | 44 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22041 | 0.030 |
Why?
|
Mastectomy | 1 | 2003 | 1834 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22025 | 0.030 |
Why?
|
Poly A | 1 | 1994 | 181 | 0.030 |
Why?
|
Membrane Potentials | 1 | 1997 | 1095 | 0.030 |
Why?
|
Suction | 1 | 2015 | 263 | 0.030 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2015 | 96 | 0.030 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1994 | 224 | 0.030 |
Why?
|
Prevalence | 1 | 2010 | 15687 | 0.030 |
Why?
|
Recurrence | 1 | 2006 | 8487 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2015 | 80301 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2020 | 961 | 0.030 |
Why?
|
Recreation Therapy | 1 | 2013 | 2 | 0.030 |
Why?
|
Disease Progression | 2 | 2014 | 13505 | 0.030 |
Why?
|
Introns | 1 | 2016 | 978 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2003 | 1718 | 0.030 |
Why?
|
Rehabilitation, Vocational | 1 | 2013 | 81 | 0.030 |
Why?
|
Periodicity | 1 | 2014 | 349 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2019 | 12412 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2014 | 541 | 0.030 |
Why?
|
Electroretinography | 1 | 2014 | 518 | 0.030 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2013 | 178 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20484 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3870 | 0.020 |
Why?
|
Magnetics | 1 | 1994 | 600 | 0.020 |
Why?
|
Occupational Therapy | 1 | 2013 | 139 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2009 | 5131 | 0.020 |
Why?
|
RNA Splicing | 1 | 2016 | 914 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 9274 | 0.020 |
Why?
|
Chronic Disease | 3 | 2014 | 9283 | 0.020 |
Why?
|
Skin Ulcer | 1 | 2012 | 129 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2016 | 1091 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 2 | 2013 | 1799 | 0.020 |
Why?
|
Down-Regulation | 1 | 1997 | 2918 | 0.020 |
Why?
|
Mental Disorders | 1 | 2010 | 6797 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 804 | 0.020 |
Why?
|
Child, Preschool | 1 | 2013 | 42034 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2391 | 0.020 |
Why?
|
Antipruritics | 1 | 2009 | 31 | 0.020 |
Why?
|
Stroke | 1 | 2012 | 9945 | 0.020 |
Why?
|
DNA | 3 | 1988 | 7236 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2013 | 536 | 0.020 |
Why?
|
Skin Temperature | 1 | 2009 | 96 | 0.020 |
Why?
|
Regression Analysis | 1 | 1998 | 6361 | 0.020 |
Why?
|
Quisqualic Acid | 1 | 2008 | 35 | 0.020 |
Why?
|
Spinothalamic Tracts | 1 | 2008 | 8 | 0.020 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2009 | 132 | 0.020 |
Why?
|
Receptors, Purinergic | 1 | 2008 | 66 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2014 | 1045 | 0.020 |
Why?
|
Virus Activation | 1 | 2010 | 319 | 0.020 |
Why?
|
Activating Transcription Factor 3 | 1 | 2008 | 53 | 0.020 |
Why?
|
Hyperemia | 1 | 2009 | 221 | 0.020 |
Why?
|
Ornithine Decarboxylase | 1 | 1987 | 64 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2008 | 373 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 893 | 0.020 |
Why?
|
Thymidine | 1 | 1987 | 299 | 0.020 |
Why?
|
2-Aminopurine | 1 | 2007 | 11 | 0.020 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4409 | 0.020 |
Why?
|
Virus Latency | 1 | 2010 | 362 | 0.020 |
Why?
|
Denervation | 1 | 2008 | 277 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2005 | 21065 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2009 | 314 | 0.020 |
Why?
|
Immunocompetence | 1 | 2007 | 137 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2009 | 13629 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2007 | 310 | 0.020 |
Why?
|
Neprilysin | 1 | 2009 | 472 | 0.020 |
Why?
|
Tibial Fractures | 1 | 2009 | 264 | 0.020 |
Why?
|
Acyclovir | 1 | 2007 | 269 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2874 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2009 | 755 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3317 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 794 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1994 | 6067 | 0.020 |
Why?
|
Valine | 1 | 2007 | 409 | 0.020 |
Why?
|
Drug Synergism | 1 | 2009 | 1755 | 0.020 |
Why?
|
Keratinocytes | 1 | 2009 | 792 | 0.020 |
Why?
|
Edema | 1 | 2009 | 772 | 0.020 |
Why?
|
Mice, Neurologic Mutants | 1 | 1984 | 107 | 0.010 |
Why?
|
Equipment Failure | 1 | 2007 | 577 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2010 | 1558 | 0.010 |
Why?
|
Body Temperature | 1 | 1987 | 777 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9531 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4938 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 1995 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39254 | 0.010 |
Why?
|
Anesthetics | 1 | 2008 | 522 | 0.010 |
Why?
|
Obesity | 1 | 2004 | 12915 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2007 | 857 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2008 | 1244 | 0.010 |
Why?
|
Treatment Failure | 1 | 2007 | 2646 | 0.010 |
Why?
|
Comprehensive Health Care | 1 | 1981 | 124 | 0.010 |
Why?
|
Thoracic Nerves | 1 | 2000 | 20 | 0.010 |
Why?
|
Cell Division | 1 | 1987 | 4462 | 0.010 |
Why?
|
Optic Nerve | 1 | 1983 | 567 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2008 | 6242 | 0.010 |
Why?
|
Trigeminal Nerve | 1 | 2000 | 248 | 0.010 |
Why?
|
Radiation Injuries | 1 | 2005 | 1183 | 0.010 |
Why?
|
United States | 1 | 2006 | 72363 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2011 | 3598 | 0.010 |
Why?
|
RNA | 1 | 1987 | 2721 | 0.010 |
Why?
|
Long-Term Care | 1 | 1981 | 628 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2013 | 3762 | 0.010 |
Why?
|
Health Facilities | 1 | 1981 | 578 | 0.010 |
Why?
|
Spinal Cord | 1 | 1984 | 1817 | 0.010 |
Why?
|
Signal Transduction | 2 | 2009 | 23363 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5230 | 0.010 |
Why?
|
Hot Temperature | 1 | 2000 | 1435 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10434 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 74269 | 0.010 |
Why?
|
Proteins | 1 | 1987 | 6030 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21378 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29950 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11902 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2000 | 2627 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 1981 | 3202 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1983 | 2094 | 0.000 |
Why?
|
Health Facility Administration | 1 | 1981 | 29 | 0.000 |
Why?
|
Aging | 1 | 2000 | 8641 | 0.000 |
Why?
|
New York | 1 | 1981 | 874 | 0.000 |
Why?
|